BLGO - BioLargo, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD

BioLargo, Inc.

14921 Chestnut Street
Westminster, CA 92683
United States

SectorBasic Materials
Full Time Employees25

Key Executives

NameTitlePayExercisedYear Born
Mr. Dennis P. CalvertChairman, Pres & CEO319.93kN/A1963
Mr. Charles K. Dargan II, C.F.A.Chief Financial OfficerN/AN/A1955
Mr. Joseph L. ProvenzanoVP of Operations, Corp. Sec. & Director186.34kN/A1969
Mr. Kenneth Reay CodeChief Science Officer & Director301.2kN/A1947
Mr. Mitch NotoDirector of Corp. Devel.N/AN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


BioLargo, Inc. operates as a technology developer and environmental engineering company in the United States. The company operates through Odor-No-More, BLEST, BioLargo Water, and Clyra Medical segments. Its platform technology, Advanced Oxidation System (AOS) is a water treatment system for decontamination and disinfection. The company offers odor and volatile organic compound control products, and AOS water treatment technologies, as well as professional engineering and consulting services. In addition, it offers wound care products for traumatic injury, diabetic ulcers, and chronic hard-to-heal wounds. The company provides its products under the CupriDyne Clean, Nature's Best Science, and Deodorall brand names. BioLargo, Inc. is based in Westminster, California.

Corporate Governance

BioLargo, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.